YOLFTbeta
Heramed Ltd

Heramed Ltd

HMD · AU · Healthcare / Medical Devices

0.035AUD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.035
Open0.035
Day Range0.035 – 0.035
52-Week Range0.03 – 0.055
Volume28.71K
Market Cap48.66M
P/E (TTM)0.00
Forward P/E0.00
EPS0.00
Dividend Yield0.00%
Beta0.05
50-Day Avg0.0382
200-Day Avg0.0403

About

HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a digital maternity and women's health platform that focuses on improving clinical outcomes while supporting more efficient and accessible models of care. The company has a collaboration agreement with Mayo Clinic. HeraMED Limited was founded in 2011 and is based in Hawthorn East, Australia.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMs. Anoushka Gungadin
  • Employees0
  • Headquarters117 Camberwell Road, Hawthorn East, VIC, Australia, 3123, Australia
  • Websitehttps://www.hera-med.com

Leadership

  • Ms. Anoushka GungadinMD, CEO & Director
  • Mr. Cameron Peter Jones C.A.CFO & Joint Company Secretary
  • Mr. Vivek KrishnanChief Technology Officer
  • Henry JordanHead of Investor Relations
  • Dr. Mandy KhairaChief Clinical Transformation Officer & Chief Medical Officer
  • Ms. Nicole ZappalaHead of Customer Success
  • Mr. Jeff GaribaldiChief Growth Officer
  • Ms. Nova Anne TaylorJoint Company Secretary

Financials

Income Statement

Currency: AUD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue0059.67K147.14K39.52K83.68K215.81K413.19K225.49K195.77K
Growth (%)---+146.58%-73.14%+111.76%+157.89%+91.46%-45.43%-13.18%
Cost of Revenue4.84K7.03K103.67K358.74K323.34K303.18K430.50K165.07K90.21K96.00K
Gross Profit-4.84K-7.03K-44.00K-211.60K-279.32K-219.50K-214.69K248.12K135.29K99.78K
Gross Margin---73.74%-143.81%-706.85%-262.30%-99.48%60.05%60.00%50.97%
Operating Expense1.95M639.09K2.18M3.06M3.17M3.71M2.95M4.79M5.70M2.76M
Operating Income-1.95M-646.13K-2.22M-3.27M-3.45M-3.93M-3.17M-4.55M-5.57M-2.66M
Operating Margin---3725.46%-2221.16%-8720.32%-4699.79%-1466.70%-1100.13%-2469.41%-1358.06%
EBITDA-1.95M-639.09K-2.22M-3.02M-3.45M-3.93M-3.17M-3.97M-3.35M-2.56M
EBITDA Margin---3725.46%-2054.09%-8720.32%-4699.79%-1466.70%-961.33%-1485.28%-1309.03%
Net Income-2.05M-791.83K-2.91M-3.17M-3.36M-5.71M-4.88M-4.50M-3.40M-2.76M
Net Income Margin---4880.82%-2152.08%-8500.28%-6822.27%-2261.58%-1089.77%-1507.04%-1408.29%
R&D1.56M242.17K524.52K933.83K1.32M1.46M747.32K1.41M1.00M685.88K
R&D as % of Total Revenue--879.00%634.65%3328.38%1746.82%346.29%340.21%445.17%350.35%
Interest Expense100.74K145.70K689.44K7.54K10.32K2.31M2.55M89.64K48.29K2.81K
Interest Expense % of Total Revenue--1155.36%5.12%26.13%2759.53%1183.75%21.69%21.42%1.43%

Balance Sheet

Currency: AUD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.73M1.25M4.27M3.61M3.17M4.57M4.19M2.01M2.78M994.94K
Total Liabilities855.26K1.05M916.32K1.22M1.19M4.13M1.30M1.55M1.06M559.96K
Total Equity872.17K201.88K3.36M2.39M1.99M-105.66K2.88M466.70K1.72M621.27K
Cash1.35M45.30K3.12M2.05M1.90M3.55M2.64M723.29K3.13M914.65K
Total Debt214.81K298.39K144.67K241.21K190.47K3.41M179.53K209.37K815.96K282.39K
Net Debt-1.13M253.09K-2.97M-1.81M-1.70M-140.48K-2.46M-513.92K-2.31M-632.27K

Cash Flow

Currency: AUD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.39M-549.66K-1.37M-2.76M-2.78M-3.23M-2.56M-5.57M-4.81M-2.44M
Investing Cash Flow-301.26K-845.09K-134.30K-209.72K-67.31K-85.43K-690.78K-2.05K0-
Financing Cash Flow2.97M81.39K4.61M833.78K2.52M4.88M2.54M2.96M6.88M1.27M
Capital Expenditure297.38K845.09K137.60K209.72K74.98K82.50K680.98K2.05K23.34
Free Cash Flow-1.68M-1.39M-1.50M-2.97M-3.17M-3.20M-3.20M-5.57M-2.98M-2.44M
FCF to OCF121.45%253.75%110.07%107.60%114.10%99.12%125.18%100.04%61.89%100.00%

Earnings

Report DateFeb 28, 2025Aug 28, 2025
EPS Estimate0.000.00
EPS Actual0.000.00
Surprise--
Timing--

Key Statistics & Ratios

Market Cap48.66M
Enterprise Value41.78M
Trailing P/E0.00
Forward P/E0.00
Price / Sales147.27
Price / Book15.12
EPS0.00
Book Value0.002
Revenue (TTM)330.44K
Gross Profit (TTM)-50.70K
EBITDA-3.68M
Profit Margin0.00%
Operating Margin-4102.08%
Return on Equity-223.73%
Return on Assets-95.09%
Shares Outstanding1.16B
Shares Float815.53M
Beta0.05
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%